ctDNA Levels Significantly Predicts Survival in NSCLC Patients with an EGFR Activating Mutation

dc.contributor.authorSanchez Herrero, E.
dc.contributor.authorFranco, F.
dc.contributor.authorAuglite, M.
dc.contributor.authorSerna Blasco, R.
dc.contributor.authorBarquin Del Romo, M.
dc.contributor.authorSanchez-Hernandez, A.
dc.contributor.authorGarcia Giron, C.
dc.contributor.authorDomine, M.
dc.contributor.authorJantus, E.
dc.contributor.authorCamps, C.
dc.contributor.authorSanchez, J. M.
dc.contributor.authorOramas, J.
dc.contributor.authorChara, L. E.
dc.contributor.authorOrtega, A. L.
dc.contributor.authorSala, M. A.
dc.contributor.authorHernandez, B.
dc.contributor.authorSereno, M.
dc.contributor.authorBosch-Barrera, J.
dc.contributor.authorPadilla, A.
dc.contributor.authorBalsalobre, J.
dc.contributor.authorBlanco, R.
dc.contributor.authorDe Castro Carpeno, J.
dc.contributor.authorMielgo Rubio, X.
dc.contributor.authorSotelo, M.
dc.contributor.authorCoves, J.
dc.contributor.authorCalvo De Juan, V.
dc.contributor.authorProvencio, M.
dc.contributor.authorRomero, A.
dc.contributor.authoraffiliation[Sanchez Herrero, E.] Biomed Sci Res Inst Puerta de Hierro Majadahonda, Liquid Biopsy Lab, Madrid, Spain
dc.contributor.authoraffiliation[Auglite, M.] Biomed Sci Res Inst Puerta de Hierro Majadahonda, Liquid Biopsy Lab, Madrid, Spain
dc.contributor.authoraffiliation[Serna Blasco, R.] Biomed Sci Res Inst Puerta de Hierro Majadahonda, Liquid Biopsy Lab, Madrid, Spain
dc.contributor.authoraffiliation[Barquin Del Romo, M.] Biomed Sci Res Inst Puerta de Hierro Majadahonda, Liquid Biopsy Lab, Madrid, Spain
dc.contributor.authoraffiliation[Romero, A.] Biomed Sci Res Inst Puerta de Hierro Majadahonda, Liquid Biopsy Lab, Madrid, Spain
dc.contributor.authoraffiliation[Franco, F.] Hosp Univ Puerta de Hierro Majadahonda, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Calvo De Juan, V.] Hosp Univ Puerta de Hierro Majadahonda, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Provencio, M.] Hosp Univ Puerta de Hierro Majadahonda, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Sanchez-Hernandez, A.] Consorcio Hosp Prov Castellon, Med Oncol Dept, Castellon de La Plana, Spain
dc.contributor.authoraffiliation[Garcia Giron, C.] Hosp Univ Burgos, Burgos, Spain
dc.contributor.authoraffiliation[Domine, M.] Hosp Fdn Jimenez Iis Fjd, Madrid, Spain
dc.contributor.authoraffiliation[Jantus, E.] Hosp Gen Valencia, Med Oncol Dept, Valencia, Spain
dc.contributor.authoraffiliation[Camps, C.] Hosp Gen Valencia, Med Oncol Dept, Valencia, Spain
dc.contributor.authoraffiliation[Jantus, E.] Fdn Invest Hosp Gen Univ Valencia, Ciberonc, Mol Oncol Lab, Valencia, Spain
dc.contributor.authoraffiliation[Camps, C.] Fdn Invest Hosp Gen Univ Valencia, Ciberonc, Mol Oncol Lab, Valencia, Spain
dc.contributor.authoraffiliation[Sanchez, J. M.] Hosp Univ La Princesa, Madrid, Spain
dc.contributor.authoraffiliation[Oramas, J.] Hosp Univ Canarias, Santa Cruz de Tenerife, Spain
dc.contributor.authoraffiliation[Chara, L. E.] Hosp Univ Guadalajara, Med Oncol Dept, Guadalajara, Spain
dc.contributor.authoraffiliation[Ortega, A. L.] Complejo Hosp Jaen, Jaen, Spain
dc.contributor.authoraffiliation[Sala, M. A.] Hosp Basurto, Bilbao, Spain
dc.contributor.authoraffiliation[Hernandez, B.] Complejo Hosp Navarra, Navarra, Spain
dc.contributor.authoraffiliation[Sereno, M.] Infanta Sofia Univ Hosp, Ss De Los Reyes, Spain
dc.contributor.authoraffiliation[Bosch-Barrera, J.] Hosp Univ Dr Josep Trueta, Catalan Inst Oncol, Girona, Spain
dc.contributor.authoraffiliation[Padilla, A.] Hosp Univ Nuestra Senora La Candelaria, San Cristobal la Laguna, Spain
dc.contributor.authoraffiliation[Balsalobre, J.] Hosp Univ Santa Lucia, Med Oncol Dept, Murcia, Spain
dc.contributor.authoraffiliation[Blanco, R.] Consorcio Hosp Terrassa, Barcelona, Spain
dc.contributor.authoraffiliation[De Castro Carpeno, J.] Hosp Univ La Paz, Madrid, Spain
dc.contributor.authoraffiliation[Mielgo Rubio, X.] Hosp Univ Fdn Alcorcon, Oncol Unit, Alcorcon, Madrid, Spain
dc.contributor.authoraffiliation[Sotelo, M.] Hosp Infanta Cristina, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Coves, J.] Hosp Son Llatzer, Mallorca, Spain
dc.date.accessioned2025-01-07T14:40:45Z
dc.date.available2025-01-07T14:40:45Z
dc.date.issued2019-10-01
dc.identifier.doi10.1016/j.jtho.2019.08.1480
dc.identifier.essn1556-1380
dc.identifier.issn1556-0864
dc.identifier.unpaywallURLhttp://www.jto.org/article/S155608641932163X/pdf
dc.identifier.urihttps://hdl.handle.net/10668/26585
dc.identifier.wosID492162203395
dc.issue.number10
dc.issue.numberS
dc.journal.titleJournal of thoracic oncology
dc.journal.titleabbreviationJ. thorac. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario de Jaén
dc.page.numberS696-S696
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.subjectctDNA levels
dc.subjectEGFR positive NSCLC
dc.titlectDNA Levels Significantly Predicts Survival in NSCLC Patients with an EGFR Activating Mutation
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number14
dc.wostypeMeeting Abstract

Files